Tolerability and Safety of Miltefosine for the Treatment of Cutaneous Leishmaniasis
Miltefosine, an orally administered drug, is an important component of the therapeutic arsenal against visceral and mucosal forms of leishmaniasis. However, data regarding the safety and tolerability of miltefosine treatment for cutaneous leishmaniasis (CL) are relatively limited. The aim of this st...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI AG
2024-09-01
|
| Edice: | Tropical Medicine and Infectious Disease |
| Témata: | |
| On-line přístup: | https://www.mdpi.com/2414-6366/9/9/218 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|